HCPCS Level II
J7614
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
Codes near J7614
These sit next to J7614 in the CMS Level II file. All J codes
- J7609Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7612Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7615Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
- J7620Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
- J7622Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7624Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7626Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00093-4145-56 | Levalbuterol | Teva Pharmaceuticals USA, Inc. | 19 |
| 00093-4146-56 | Levalbuterol | Teva Pharmaceuticals USA, Inc. | 38 |
| 00093-4148-56 | Levalbuterol | Teva Pharmaceuticals USA, Inc. | 75 |
| 00115-9930-78 | Levalbuterol | Amneal Pharmaceuticals, LLC | 16 |
| 00115-9931-78 | Levalbuterol | Amneal Pharmaceuticals, LLC | 32 |
| 00115-9932-78 | Levalbuterol | Impax Laboratories, LLC | 63 |
| 00378-9690-52 | Levalbuterol | Mylan Pharmaceuticals Inc. | 16 |
| 00378-9691-52 | Levalbuterol | Mylan Pharmaceuticals Inc. | 32 |
| 00378-9692-52 | Levalbuterol | Mylan Pharmaceuticals Inc. | 63 |
| 35573-0443-25 | Levalbuterol Hydrochloride | Burel Pharmaceuticals, LLC | 16 |
| 35573-0444-25 | Levalbuterol Hydrochloride | Burel Pharmaceuticals, LLC | 32 |
| 35573-0445-25 | Levalbuterol Hydrochloride | Burel Pharmaceuticals, LLC | 63 |
| 50090-6377-00 | Levalbuterol | A-S Medication Solutions | 33 |
| 76204-0700-01 | Levalbuterol | Ritedose Pharmaceuticals, LLC | 19 |
| 76204-0700-25 | Levalbuterol | Ritedose Pharmaceuticals, LLC | 16 |
| 76204-0800-01 | Levalbuterol | Ritedose Pharmaceuticals, LLC | 38 |
| 76204-0800-25 | Levalbuterol | Ritedose Pharmaceuticals, LLC | 32 |
| 76204-0900-01 | Levalbuterol | Ritedose Pharmaceuticals, LLC | 75 |
| 76204-0900-25 | Levalbuterol | Ritedose Pharmaceuticals, LLC | 63 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.